Skip to main content
Equibles

PNC FINANCIAL SERVICES GROUP, INC.

Position in AKTS — Aktis Oncology, Inc.

CIK 713676 Pittsburgh, PA
Back to AKTS Full portfolio

Position in AKTS

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$197,891
+$73,593 QoQ
Shares Held
6,140
-11.6% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 114 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKTS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PNC FINANCIAL SERVICES GROUP, INC. holds $113,432,736 across 262 Biotechnology names. AKTS ranks #57 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 69,358 $34,452,195
2 REGN
Regeneron Pharmaceuticals, Inc.
 16,662 $10,389,420
3 TECH
BIO-TECHNE Corp
 77,074 $5,445,277
4 MRNA
Moderna, Inc.
 70,829 $4,960,151
5 TGTX
Tg Therapeutics, Inc.
 89,646 $4,925,149
6 DNTH
Dianthus Therapeutics, Inc. /DE/
 39,473 $3,847,827
7 INCY
Incyte Corp
 32,777 $3,715,597
8 ARGX
Argenx SE
 3,967 $3,680,460

All Filings in AKTS

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $197,891 6,140
2026-03-31 $124,298 6,948